tiprankstipranks
Viracta Therapeutics (VIRX)
OTHER OTC:VIRX
US Market

Viracta Therapeutics (VIRX) Technical Analysis

Compare
928 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Viracta Therapeutics’s (VIRX) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Viracta Therapeutics is a Sell.
Viracta Therapeutics’s (VIRX) 20-Day exponential moving average is 0.06, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) 50-Day exponential moving average is 0.12, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.

Viracta Therapeutics (VIRX) Pivot Points

Feb 21, 2025, 10:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
>-0.01
<0.01
0.02
0.03
0.05
0.06
0.08
Fibonacci
<0.01
0.02
0.02
0.03
0.04
0.05
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viracta Therapeutics (VIRX) Moving Averages

Feb 21, 2025, 10:22 AM
Period
Simple
Exponential
MA5
0.03Buy
0.03Buy
MA10
0.02Buy
0.03Sell
MA20
0.07Sell
0.06Sell
MA50
0.14Sell
0.12Sell
MA100
0.17Sell
0.19Sell
MA200
0.33Sell
0.38Sell
Viracta Therapeutics’s (VIRX) 10-Day exponential moving average is 0.03, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) 100-Day exponential moving average is 0.19, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 50-day simple moving average is 0.14, creating a Sell signal.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 100-day simple moving average is 0.17, creating a Sell signal.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 200-day simple moving average is 0.33, creating a Sell signal.

Viracta Therapeutics (VIRX) Technical Indicators

Feb 21, 2025, 10:22 AM
Name
Value
Implied Action
RSI (14)
31.66
Neutral
STOCH (9,6)
63.51
Neutral
STOCHRSI (14)
14.42
Buy
MACD (12,26)
-0.04
Sell
ADX (14)
34.03
Neutral
Williams %R
-85.33
Buy
CCI (14)
-45.11
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
62.16
Neutral
ROC
-81.25
Sell
Viracta Therapeutics’s (VIRX) Relative Strength Index (RSI) is 31.66, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Trend Strength Indicator (ADX) is 34.03, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Commodity Channel Index (CCI) is -45.11, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Price Rate of Change (ROC) is -81.25, creating a Sell signal.

FAQ

Is VIRX a Buy, Hold, or Sell?
Based on VIRX’s technical indicators, VIRX is a Sell.
    What is VIRX’s RSI (14)?
    VIRX’s RSI (14) is 31.66, which suggests VIRX is a Neutral.
      What is VIRX’s MACD?
      VIRX’s MACD is -0.04, which suggests VIRX is a Sell.
        What is VIRX’s 5-day moving average?
        VIRX’s 5-day moving average is 0.03, which suggests VIRX is a Buy.
          What is VIRX’s 20-day moving average?
          VIRX 20-day moving average is 0.07, which suggests VIRX is a Sell.
            What is VIRX’s 50-day moving average?
            VIRX’s 50-day moving average is 0.14, which suggests VIRX is a Sell.
              What is VIRX’s 200-day moving average?
              VIRX’s 200-day moving average is 0.33, which suggests VIRX is a Sell.
                What is VIRX’s Williams % R (14)?
                VIRX’s Williams % R (14) is -85.33, which suggests VIRX is a Buy.
                  What is VIRX’s CCI (14)?
                  VIRX’s CCI (14) is -45.11, which suggests VIRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis